288 results on '"Ishii, Ken J"'
Search Results
2. Acute malaria suppresses the B lymphocytic niche in the bone marrow through the alteration of CXCL12-abundant reticular cells
3. Integrin α5 regulates motility of human monocyte‐derived Langerhans cells during immune response
4. Virological characteristics of the SARS-CoV-2 JN.1 variant
5. Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine
6. TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model
7. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a Partial STING Agonist, Competes for Human STING Activation
8. Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism
9. Prime-boost-type PspA3 + 2 mucosal vaccine protects cynomolgus macaques from intratracheal challenge with pneumococci
10. Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
11. Challenges in developing personalized neoantigen cancer vaccines
12. Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community’s view
13. Identification of a Self-Assembling Small-Molecule Cancer Vaccine Adjuvant with an Improved Toxicity Profile
14. Secretion of mitochondrial DNA via exosomes promotes inflammation in Behçet's syndrome
15. Corrigendum: Dendritic cell proliferation by primary cilium in atopic dermatitis
16. Intratumoural Delivery of mRNA Loaded on a Cationic Hyper-Branched Cyclodextrin-Based Polymer Induced an Anti-Tumour Immunological Response in Melanoma
17. Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody
18. A combination of TLR9 and STING agonists induces potent neopeptide-specific T cell immunity and improves ICB efficacy in tumor models
19. Dendritic cell proliferation by primary cilium in atopic dermatitis
20. TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells
21. Roles of TRPM4 in immune responses in keratinocytes and identification of a novel TRPM4-activating agent
22. Supplementary Figure Legends from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
23. Supplementary Figure 6 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
24. Supplementary Figure 3 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
25. Supplementary Figure 5 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
26. Data from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
27. Supplementary Figure 2 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
28. Supplementary Figure 4 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
29. Supplementary Figure 7 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
30. Data from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
31. Supplementary Figure 1 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
32. Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice
33. A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component
34. Anti-Inflammatory Role of TRPV4 in Human Macrophages
35. Oncolytic adenovirus serotype 35 mediated tumor growth suppressionviaefficient activation and tumor infiltration of natural killer cells
36. Alveolar macrophages instruct CD8+ T cell expansion by antigen cross-presentation in lung
37. Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein
38. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
39. Proposal for the revision of guidelines for clinical trials of vaccines to prevent infectious diseases in Japan
40. Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen
41. CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
42. Identification of RPL15 60S Ribosomal Protein as a Novel Topotecan Target Protein That Correlates with DAMP Secretion and Antitumor Immune Activation
43. Nucleic Acid-based Immuno-prophylaxis and -therapies against Tropical Diseases
44. Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-β-cyclodextrin: A phase 1 clinical trial
45. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
46. Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine Adjuvants
47. Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation
48. Proposal for the revision of the guidelines for Non-clinical studies of vaccines for the prevention of infectious diseases in Japan
49. Making innate sense of mRNA vaccine adjuvanticity
50. CpG ODN (K3)—Toll-Like Receptor 9 Agonist—Induces Th1-type Immune Response and Enhances Cytotoxic Activity in Advanced Lung Cancer Patients: A Phase I Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.